Skip to main content

Incyte statistics

  • INCY · Nasdaq
  • Biotechnology
  • S&P 500
$120.97−0.60%Close 13 Nov 2026 · Market value $24.67B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Incyte is valued at $24.67B on its latest close. Its price is 61.2 times its earnings.

Market value$24.67B
Enterprise value$21.43B
Price / earnings61.15
Price / sales4.10
Price / book4.37
EV / EBITDA29.57
EV / sales3.57
Price / free cash flow36.02
Price / free cash flow, own 5-year average54.15
EV / EBIT34.20
EV / free cash flow31.28
Free cash flow yield2.8%

Share price

Latest close$120.97
Day's change−0.6%
52-week high$132.60
52-week low$89.25
From 52-week high−8.8%
Return · 1 month+7.0%
Return · 3 months−4.9%
Return · year to date+22.5%
Return · 1 year+11.7%
Beta · 1 year against the S&P 5000.47
50-day average$119.18
200-day average$108.92
RSI 1454.2
Average volume · 20 sessions1.8M

Margins and returns

For fiscal 2025, as filed.

Gross margin92.8%
Operating margin29.5%
Net margin25.0%
Free cash flow margin26.3%
Return on equity29.9%
Return on assets18.9%
Return on invested capital51.2%
Return on invested capital, 5-year average25.5%
Return on capital employed32.8%
Stock-based compensation / revenue4.8%

Financial position

At the end of fiscal 2025.

Cash and equivalents$3.10B
Total debt$54.92M
Net debt−$3.04B
Current ratio3.32
Quick ratio2.28
Debt / equity0.01
Net debt / EBITDA−1.89
Interest coverage623.91

Growth

Revenue, latest quarter on a year+14.0%
Revenue, twelve months on a year+24.9%
EPS, latest quarter on a year−283%
EPS, twelve months on a year−66.8%
Revenue, 5-year compound+14.0%
Revenue, 10-year compound+21.2%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares201M
Shares outstanding, 5-year compound−1.6%
Net share repurchases$0.00

Taxes

For fiscal 2025, as filed.

Income tax expense$377.8M
Effective tax rate22.7%

INCY in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.